As knowledge on the importance of SOCE in tumor biology and cancer progression accumulates, the blockade of STIM1/Orai1-dependent Ca2+ signaling has emerged as the potential and plausible targets for cancer therapeutics. This evidence concerns the gene STIM1 and neoplasm.